Literature DB >> 11598843

Variation of human immunodeficiency virus type 1 viral RNA levels in the female genital tract: implications for applying measurements to individual women.

R W Coombs1, D J Wright, P S Reichelderfer, D N Burns, J Cohn, S Cu-Uvin, P A Baron, M H Cohen, A L Landay, S Lewis, A Kovacs.   

Abstract

The short-term detection and variability of human immunodeficiency virus type 1 (HIV-1) RNA level was assessed in the blood plasma and genital tracts of 55 HIV-1-infected women. Specimens were collected weekly for 8 weeks from the endocervical canal with wicks and cytobrushes and from the ectocervix and vagina with cervicovaginal lavage. In all, 48 women (87.3%) had detectable genital tract HIV-1 RNA at > or =1 collection times. HIV-1 RNA levels varied least in specimens from endocervical canal wick and most in cervicovaginal lavage samples. The within-subject variation for genital-tract virus level was greater than that for blood. Overall, the odds for viral RNA detection in the genital tract approximately tripled for each 10-fold increase in plasma viral RNA concentration (P<.001) or with concomitant genital tract infection (P=.003). Endocervical canal wicks should be considered as an adjunct to cervicovaginal lavage, to improve the sensitivity and precision of HIV-1 RNA detection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11598843     DOI: 10.1086/323660

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

1.  Determinants of HIV shedding in the lower genital tract of women.

Authors:  Brenna L Anderson; Susan Cu-Uvin
Journal:  Curr Infect Dis Rep       Date:  2008-11       Impact factor: 3.725

2.  High discordance in blood and genital tract HIV-1 drug resistance in Indian women failing first-line therapy.

Authors:  Shanmugam Saravanan; Selvamurthi Gomathi; Allison Delong; Bagavathi Kausalya; Sathasivam Sivamalar; Selvamuthu Poongulali; Katherine Brooks; Nagalingeswaran Kumarasamy; Pachamuthu Balakrishnan; Sunil S Solomon; Susan Cu-Uvin; Rami Kantor
Journal:  J Antimicrob Chemother       Date:  2018-08-01       Impact factor: 5.790

3.  Evidence for both Intermittent and Persistent Compartmentalization of HIV-1 in the Female Genital Tract.

Authors:  Batsirai M Mabvakure; Bronwen E Lambson; Kavisha Ramdayal; Lindi Masson; Dale Kitchin; Mushal Allam; Salim Abdool Karim; Carolyn Williamson; Jo-Ann Passmore; Darren P Martin; Cathrine Scheepers; Penny L Moore; Gordon W Harkins; Lynn Morris
Journal:  J Virol       Date:  2019-05-01       Impact factor: 5.103

4.  Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy.

Authors:  Michael N Neely; Lorie Benning; Jiaao Xu; Howard D Strickler; Ruth M Greenblatt; Howard Minkoff; Mary Young; James Bremer; Alexandra M Levine; Andrea Kovacs
Journal:  J Acquir Immune Defic Syndr       Date:  2007-01-01       Impact factor: 3.731

5.  Comparison of polyclonal expansion methods to improve the recovery of cervical cytobrush-derived T cells from the female genital tract of HIV-infected women.

Authors:  Alfred Bere; Lynette Denny; Willem Hanekom; Wendy A Burgers; Jo-Ann S Passmore
Journal:  J Immunol Methods       Date:  2010-02-08       Impact factor: 2.303

6.  Effect of the levonorgestrel intrauterine device on genital HIV-1 RNA shedding among HIV-1-infected women not taking antiretroviral therapy in Nairobi, Kenya.

Authors:  Jenell S Coleman; Christina Mwachari; Jennifer Balkus; Lucy Sanguli; Angela Muliro; Kathy Agnew; Robert W Coombs; Craig R Cohen; Jane Hitti
Journal:  J Acquir Immune Defic Syndr       Date:  2013-06-01       Impact factor: 3.731

7.  Is there an association between HIV-1 genital shedding and cervical intraepithelial neoplasia 2/3 among women on antiretroviral therapy?

Authors:  Megan Justine Huchko; Victoria Woo; Teri Liegler; Anna Leddy; Karen Smith-McCune; George F Sawaya; Elizabeth A Bukusi; Craig R Cohen
Journal:  J Low Genit Tract Dis       Date:  2013-07       Impact factor: 1.925

8.  Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy.

Authors:  Kenneth H Fife; Julia W Wu; Kathleen E Squires; D Heather Watts; Janet W Andersen; Darron R Brown
Journal:  J Acquir Immune Defic Syndr       Date:  2009-07-01       Impact factor: 3.731

9.  Use of Sno Strip filter-paper wicks for collection of genital-tract samples allows reproducible determination of human immunodeficiency virus type 1 (HIV-1) RNA viral load with a commercial HIV-1 viral load assay.

Authors:  Christopher H Sherlock; Paula M Lott; Deborah M Money; Linda Merrick; Yasemin Arikan; Valencia P Remple; Kevin Craib; David R Burdge
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

10.  Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial.

Authors:  Jared M Baeten; Lara B Strick; Aldo Lucchetti; William L H Whittington; Jorge Sanchez; Robert W Coombs; Amalia Magaret; Anna Wald; Lawrence Corey; Connie Celum
Journal:  J Infect Dis       Date:  2008-12-15       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.